SourceOne Stock Info Your one source site for stock research

Company Website

Investor Relations

What’s the buzz—

message boards

Yahoo

Market Watch

Money Central

Raging Bull

Board Central

Amylin Pharmaceuticals, Inc.

AMLN

Amylin Pharmaceuticals is a biopharmaceutical company engaged in the research, development and commercialization of drug candidates for the treatment of diabetes, obesity and cardiovascular disease. Amylin has two lead drug candidates in late stage development for the treatment of diabetes, SYMLIN (pramlintide acetate) and exenatide. Its drug candidates for the potential treatment of obesity are AC137 and AC162352. Drug candidates for the treatment of cardiovascular disease are AC2592 (glucagon-like peptide (GLP-1)), and AC3056.

Stock Quotes and Other Information

Nasdaq	NYSE	Msn	Yahoo	Silicon Investor
Excite	Lycos	Market Watch	Clear Station	StockHouse

SourceOne Message Board

Search for Stocks:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Alphabetical Listings by Company Name

S&P 100 S&P 500 S&P 400 Dow Jones Industrials Dow Jones Transportation Dow Jones Utilities Dow Jones Composite Nasdaq 100 Morgan Stanley Hi-Tech 35

Home